Success Story: Record-Speed EB1A Win for Indian Research Scientist – Approved in Just 12 Days With Our Expert Filing and Direct Premium Service

 

Client’s Testimonial:

“Thank you very much for your support during case preparation.


On February 25th, 2025, we received another EB-1A (Alien of Extraordinary Ability) approval for a Research Scientist in the Field of Medicinal Chemistry (Approval Notice).


General Field: Medicinal Chemistry

Position at the Time of Case Filing: Research Scientist

Country of Origin: India

State of Residence at the Time of Filing: Louisiana

Approval Notice Date: February 25th, 2025

Processing Time: 12 days (Premium Processing Requested)


Case Summary:     

We are pleased to share the success story of an EB1A (Alien of Extraordinary Ability) approval granted to a medicinal chemistry expert whose work focuses on designing and synthesizing novel organic compounds with therapeutic applications. At the time of filing, the client was engaged in groundbreaking research that bridged sustainable chemical synthesis with real-world pharmaceutical innovation. After careful evaluation, NAILG recognized the client as an exceptional candidate for EB1A classification.

Research Focus and Contributions:
 The petition highlighted the client’s specialized expertise in medicinal chemistry, particularly in developing innovative synthesis processes that address critical needs in modern therapeutics. A notable achievement includes the sustainable synthesis of amidoalkyl naphthols catalyzed by silica sulfuric acid (SSA), a method with broad implications for safer, more efficient drug development. The client’s work spans applications in medicinal compound design, process optimization, and novel therapeutic agent creation.

Research Impact and Scientific Contributions:
 To demonstrate the client’s influence and national significance, the petition presented evidence including:

  • Publications: 16 peer-reviewed journal articles (9 first-authored), 1 patent, 1 patent application, and 1 book.
  • Citations: 301 citations on Google Scholar, reflecting the reach and influence of the client’s findings in the medicinal chemistry community.
  • Peer Review Activity: At least 50 reviews for high-impact scientific journals, underscoring their role in maintaining scholarly standards.

Support from Experts in the Field:
 The petition was reinforced with 5 strong letters of recommendation from respected scholars and professionals in the field. These letters attested to the client’s sustained influence, leadership, and originality in medicinal chemistry, as well as the significant real-world applications of their research.

Well Positioned to Advance the Proposed Endeavor:
 We demonstrated that the client’s advanced training in chemistry, coupled with their proven record of innovation in both laboratory and applied research settings, uniquely positions them to make continued breakthroughs in drug discovery and development. Their pioneering work in sustainable synthesis directly contributes to creating safer and more effective treatments for a range of diseases.

EB1A Approval and Outlook:
 Approved in February 2025, the EB1A petition recognized the client’s extraordinary achievements and future potential to advance medicinal chemistry in ways that benefit public health and the pharmaceutical industry. NAILG is proud to have represented this accomplished researcher and looks forward to their continued contributions to science and innovation.

--------------------------------------------

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With nearly 64,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Tens of Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our cumulative total of approved cases grew from 600 in 2013 to nearly 64,000 in 2025.


Track Record of Success EB-1 and NIW Approvals

(2020.01 - 2024.12)
Category Approval or Refund® Approval or RefilingTM
Approved Sum Success Rate Approved Sum Success Rate
NIW 28,946 99.52% 3,030 98.31%
EB1A 4,322 91.76% 2,870 88.91%
EB1B 793 98.51% 236 90.77%
Total 34,061 98.44% 6,136 93.39%


Approval Notices: https://www.wegreened.com/eb1_niw_approvals

Success Stories: https://www.wegreened.com/blog/

Website: www.wegreened.com

Free evaluation: https://www.wegreened.com/Free-Evaluation

Tel: 888.666.0969 (Toll Free)


To see more clients’ testimonials and approvals, please refer to:

Client's Testimonials

Approval Notices

To Learn More About Your Options CLICK HERE


Copyright © North America Immigration Law GroupWeGreened.com, All Rights Reserved.